-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the 18th, Enhua Pharmaceutical announced that the company has recently obtained the "Drug Registration Certificate" for the psychotropic drug duloxetine hydrochloride enteric-coated capsules 20mg, 30mg, and 60mg approved and issued by the National Medical Products Administration
.
It is understood that duloxetine hydrochloride enteric-coated capsules indications: depression; generalized anxiety disorder; chronic musculoskeletal pain
.
The product has been included in the "National Medical Insurance Catalog" Class B drugs